Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


J.P. Morgan Notebook Day 3: Lilly's CGRP Prospects, Juno On Track, Color From Alnylam's Greene, Shire's New CMO

Executive Summary

Daily round-up of news and notes from the 2018 J.P. Morgan Healthcare Conference in San Francisco: Lilly CEO on CGRP reimbursement jitters, Alnylam president on Sanofi deal terms, Juno stakes BCMA myeloma claim, Shire's new CMO.


Related Content

Deal Watch: As J.P. Morgan Waits For New Deals, Sanofi Takes Care Of Old Business
Celgene's CAR-T Leadership Goals Advance At ASH 2017
Shire Tempts Busch From Bayer As It Eyes Top Spot In Rare Diseases
Novartis Floats 'Bold' Value-Based Reimbursement Idea In Migraine
Interview: Alnylam President On Patisiran Lift-Off Plans
CAR-T To Go: Juno Sees JCAR017 As Safer, Suited For Outpatients
Phase III Lasmiditan Data Strengthens Lilly's Dual Migraine Strategy
Shire Aims To Stay On Top In Hemophilia With Novimmune Pact
Shire CEO Says Lanadelumab Results Vindicate Dyax Buy, M&A Strategy
JP Morgan: Brandicourt Signals M&A Interest To Boost Sanofi's Growth


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts